Hjem › KOLS › Indiana › Indianapolis
Kliniske studier for KOLS i Indianapolis, IN
6 studier for KOLS søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RekruttererFase 2
- DM Clinical Research-Indianapolis, Indianapolis
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
- Indiana University Health University Hospital, Indianapolis
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RekruttererFase 3
- Indy Clinical Research- Site Number : 8400071, Indianapolis
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RekruttererFase 3
- Research Site, Indianapolis
- Research Site, Indianapolis
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
RekruttererObservasjonsstudie
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
Acoustic Waveform Respiratory Evaluation
RekruttererFrivillige helsepersonell ønskes velkommen
- Indiana University, Indianapolis
KOLS-studier i andre byer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Brystkreft20 studier
- Fedme20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Lungekreft16 studier
- Kardiovaskulær sykdom16 studier
- Type 1-diabetes14 studier
- Endometriekreft14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.